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Abstract 
The diversion of MHC class II-restricted thymocytes into the regulatory T (Treg) cell 
lineage is driven by intrathymic encounter of agonist self-antigens, in a similar manner 
to the clonal deletion of thymocytes. Somewhat paradoxically, it thus seems that the 
expression of an autoreactive T cell receptor is a shared characteristic of T cells that 
are subject to clonal deletion and T cells that are diverted into the Treg cell lineage. 
Here, we discuss how thymocyte-intrinsic and thymocyte-extrinsic determinants may 
specify the choice between these two fundamentally different T cell fates. 
 
This Review is dedicated to the memories of Bruno Kyewski and Harald von Boehmer, 
who both made seminal contributions to our understanding of central tolerance and 
who passed away in 2018. 
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Introduction 
A series of landmark studies in the late 1980s confirmed the longstanding hypothesis 
that tolerance to ‘self’ involves the clonal deletion in the thymus of T cells with 
potentially dangerous, self-reactive T cell receptors (TCRs)1,2. Around the same time, 
the transplantation of thymic epithelium was reported to confer a mode of tolerance to 
donor-type tissues that could not be explained by recessive tolerance mechanisms 
such as clonal deletion, as it was transferrable to naive animals through the injection 
of lymphocytes and hence was referred to as dominant tolerance 3-5. Several 
independent lines of investigation subsequently illustrated the importance of dominant 
tolerance by showing that the elimination of particular subsets of CD4+ T cells, all later 
shown to be the equivalent of forkhead box protein P3 (FOXP3)+ regulatory T (Treg) 
cells, unleashed a latent autoimmune potential in the normal T cell repertoire6-8. It is 
believed that approximately 80% of the Treg cell repertoire originates from the thymus 
(known as thymus-derived Treg cells)9,10, where FOXP3+ Treg cell differentiation can be 
‘instructed’ by encounter of agonist self-antigen11,12. Thus, the recognition of self during 
thymocyte differentiation can not only generate ‘holes’ in the T cell repertoire by clonal 
deletion, but also specify the diversion of cells into a self-reactive T cell lineage that 
lacks autoimmune potential and instead confers tolerance through immune regulation. 
 
The conceptually most simple models to explain these markedly different outcomes of 
self-antigen recognition in the thymus are based on the affinity and/or avidity of the 
underlying TCR–peptide–MHC (TCR–pMHC) interactions (FIG. 1). 
 
 
Recessive tolerance 
Any mode of tolerance that depends on clonal deletion or anergy induction. The term 
recessive refers to the fact that in order to be effective, essentially all self-reactive T 
cells need to be physically eliminated or functionally inactivated. 
 
Dominant tolerance 
Any mode of tolerance that depends on the suppressive action of regulatory cells and 
can therefore be transferred from tolerant to naive individuals. 
 
Thymus-derived Treg cells 
These cells enter the Treg cell lineage as a consequence of cell fate specification during 
T cell maturation in the thymus. By contrast, peripherally derived Treg cells arise 
through conversion of conventional FOXP3–CD4+ cells in secondary lymphoid organs. 
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However, although there is little doubt that TCR signals crucially impact the cell fate 
decisions of thymocytes, reductionist ‘signal strength’ models do not explain 
phenomena such as the intraclonal competition between Treg cell precursors13,14, the 
overlapping TCR repertoires of conventional T cells and Treg cells15,16 or the 
concomitant clonal deletion that occurs in essentially all TCR transgenic systems 
where neo-antigen expression drives efficient Treg cell diversion17-20. All of these 
observations argue against the existence of sharply demarcated affinity and/or avidity 
thresholds that separate clonal deletion and Treg cell diversion. In this Review, we 
discuss how the cell fate choice between clonal deletion and diversion into the Treg cell 
lineage may be influenced by distinct modalities of intrathymic self-antigen expression 
and presentation, spatio-temporal aspects of thymocyte differentiation and ‘contextual’ 
input that accompanies the agonist TCR signal. 
 
Topology of self-antigen expression 
Self-antigens can be broadly categorized into those with a ubiquitous expression 
pattern and those with an expression pattern that is confined to one or a few anatomical 
sites, known as tissue-restricted antigens (TRAs). It is now widely recognized that 
TRAs are also likely to be ‘visible’ to the nascent T cell repertoire, owing to the 
phenomenon of promiscuous gene expression in medullary thymic epithelial cells 
(mTECs) (BOX 1). Although it is undisputed that promiscuous gene expression 
extends the scope of central tolerance to a much broader spectrum of self-antigens 
than previously appreciated, insights are only beginning to emerge regarding whether 
and how distinct patterns of antigen expression may specify the mechanism of central 
tolerance induction for CD4+ T cells and how this affects the composition of the 
polyclonal TCR repertoire. 
 
 
 
 
Tissue-restricted antigens 
(TRAs). Self-antigens that are expressed by only one or a few peripheral tissues. The 
term TRA is an operational definition based on available expression catalogues, 
according to which TRAs are expressed in less than 5 tissues of 60 tested. 
 
Central tolerance 
Any mechanism of tolerance that shapes the T cell receptor composition and 
functionality of the T cell repertoire during selection in the thymus.  
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Two recent studies used MHC class II tetramer technology to trace the fate of small 
cohorts of polyclonal CD4+ T cells when their cognate antigens were expressed as 
neo-self antigens under the control of various promoters to achieve either a ubiquitous 
or a TRA-like expression pattern21,22. Ubiquitous antigen expression led to a large-
scale reduction in the number of antigen-specific CD4+ T cells, which was evident 
already in the nascent CD4+ single positive (SP) compartment, indicating efficient 
clonal deletion. By contrast, under circumstances of TRA-like antigen expression, 
antigen-specific CD4+ T cells were only mildly or not at all affected in terms of their 
absolute numbers yet harboured a substantial fraction of FOXP3+ Treg cells. On this 
basis, it was suggested that the mechanism of CD4+ T cell tolerance is determined by 
the antigen expression pattern, whereby ubiquitous expression favours deletional 
tolerance, whereas TRA-like modalities of antigen expression promote diversion into 
the Treg cell lineage. 
 
Studies in mice lacking the autoimmune regulator protein (AIRE) (Aire–/– mice), which 
have decreased expression of many TRAs, are consistent with a role of TRAs in Treg 
cell generation. For example, large-scale TCR sequencing revealed ‘holes’ in the Treg 
cell repertoire of Aire–/– mice, and an intact Aire gene was crucial for the capacity of 
several TCRs of unknown specificity from naturally occurring Treg cells to promote 
intrathymic clonal diversion into the Treg cell lineage23,24. In further support of TRAs 
shaping the composition of the Treg cell repertoire, adoptively transferred neonatal Treg 
cells from Aire+/+ mice, but not Aire–/– mice, prevented the autoimmune manifestations 
seen in AIRE-deficient mice25. 
 
 
 
MHC class II tetramer 
A staining reagent used to detect antigen-specific CD4+ T cells. It consists of four 
recombinantly expressed biotinylated MHC class II molecules (each carrying a 
covalently attached peptide epitope of interest) that are tetramerized via a 
fluorochrome-labelled streptavidin core.  
 
Autoimmune regulator protein 
(AIRE). AIRE was discovered through genetic mutation in patients with the 
monogenically inherited disease autoimmune polyendocrine syndrome 1 (APS1). It is 
a transcriptional regulator that controls the expression of TRAs in mTECs, but may 
also have similar or distinct functions in cells other than mTECs. 
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Although these findings establish that intrathymic antigen expression in a TRA-like 
manner can specify Treg cell diversion, they do not rule out that promiscuous gene 
expression also contributes to clonal deletion. Indeed, observations in several TCR-
transgenic systems have linked promiscuous gene expression and AIRE expression 
to deletional CD4+ T cell tolerance26-29. Similarly, tetramer-based studies showed that 
polyclonal CD4+ T cells specific for an eye-restricted TRA were deleted in an AIRE-
dependent manner30. Expression of green fluorescent protein (GFP) as a TRA-like 
neo-self antigen under the control of the insulin promoter resulted in a significant 
decrease in the number of polyclonal GFP-specific CD4+ T cells coincident with the 
emergence of FOXP3+ cells among the remainder of GFP-specific cells, which 
suggests that clonal deletion and diversion into the Treg cell lineage occurred in 
parallel22. Of note, the intensity of tetramer staining on these Treg cells was lower as 
compared with their naive counterparts in the absence of GFP, which suggests that T 
cell clones expressing TCRs with high affinity for GFP may have been deleted.  
 
In sum, the propensity of ubiquitous versus TRA-like modes of antigen expression to 
favour clonal deletion versus Treg cell development, respectively, may relate to 
quantitative differences in the amount of self-antigen, which is in keeping with an 
avidity-based model. However, as we discuss in the following sections, we also need 
to consider the following factors: the different spatial distribution of antigen expression 
and consequently the developmental stage at which these antigens are first seen by a 
thymocyte; the likelihood and frequency of serial antigen encounters; the antigen-
presenting cell (APC) type(s) that display the respective self-antigen; and, related to 
this, the co-signals such as cytokines or co-stimulatory molecules that accompany the 
TCR signal.  
 
T cell developmental stage 
Intrathymic T cell development is characterized by a highly ordered migration of 
thymocytes between distinct areas of the thymus31,32. Ubiquitously expressed antigens 
are expected to be visible to developing thymocytes in the cortex as soon as these 
cells express a functionally rearranged TCR at the CD4+CD8+ double positive (DP) 
stage. By contrast, owing to their confined expression in mTECs, TRAs are expected 
to be encountered only after CD4+ or CD8+ lineage-committed SP T cells have 
relocated to the medulla33. This raises the question of how the developmental stage at 
which thymocytes receive an agonist TCR signal influences the mode of tolerance. 
Remarkably, despite relatively low levels of TCR expression on the surface of DP 
thymocytes, they are exquisitely sensitive to antigen. In fact, whereas the estimated 
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minimum number of pMHC complexes required to activate mature peripheral T cells is 
believed to be in the order of 100, as few as one or two agonist pMHC complexes 
seem to be sufficient to elicit clonal deletion at the DP thymocyte stage34,35. Importantly, 
this implies that at the DP stage (and at least for high-affinity TCR–pMHC 
combinations), there is almost no possibility of a lower avidity interaction as a 
consequence of lower pMHC density that might favour Treg cell diversion. 
 
Indeed, although it is well established that cortical antigen encounter by DP 
thymocytes can result in clonal deletion36,37, its contribution to Treg cell differentiation 
remains contentious. For example, FOXP3-expressing cells are almost exclusively 
confined to the thymic medulla, a compartment that contains hardly any DP cells. In 
addition, the delayed appearance of FOXP3+ cells in ontogeny or in bone-marrow 
chimeras suggests that entry into the Treg cell lineage requires thymocyte maturation 
beyond the DP stage and/or involves medulla-associated signals38,39. Such 
correlations entail the caveat that the timing and intrathymic positioning of FOXP3 
expression may be poor indicators of when and where the underlying TCR stimulus 
occurred (as the transit time through the DP compartment may be shorter than the 
temporal delay between a TCR signal being received and FOXP3 expression being 
induced), but it is clear that antigen encounter at the DP stage is not a prerequisite for 
Treg cell differentiation. Instead, diversion into the Treg cell lineage can efficiently be 
initiated at the SP stage, as shown by intrathymic transfer of antigen-naive CD4+ SP 
cells into an antigen-expressing thymus40. These experiments also showed that the 
propensity of CD4+ SP cells to enter the Treg cell lineage inversely correlated with their 
progressive maturation — that is, more mature cells were less likely to become Treg 
cells (and instead underwent proliferative expansion). Although this is reminiscent of a 
previously recognized similar transition from deletion susceptibility to deletion 
resistance at the CD4+ SP cell stage41, it is tempting to speculate that the 
developmentally programmed predisposition to undergo Treg cell differentiation is 
maintained for longer during CD4+ SP cell maturation than is the susceptibility to 
undergo clonal deletion. 
 
On the basis of these combined results, it is conceivable that thymocytes transit 
through cell-intrinsically regulated developmental ‘windows of opportunity’ in which 
antigen encounter is differentially interpreted (FIG. 2). Whereas susceptibility to clonal 
deletion is established early at the DP thymocyte stage, the capacity for Treg cell 
differentiation may only be acquired in close temporal proximity to CD4+ lineage 
commitment and the relocation of CD4+ SP cells to the medulla. This offers an 
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explanation as to why CD4+ T cell tolerance to ubiquitously expressed and hence early-
encountered antigens may preferentially operate through clonal deletion. By contrast, 
a TRA-like pattern of antigen expression in the medulla would be permissive (but not 
per se instructive) for Treg cell differentiation, because these antigens are likely to be 
seen only once the capacity to undergo Treg cell differentiation has been established. 
Whether antigen recognition at this late stage induces clonal deletion or Treg cell 
differentiation might then be determined by asynchronous loss of the susceptibility to 
assume either cell fate, or by the modalities of TCR signalling in conjunction with other 
parameters, as discussed below. 
 
Serial antigen encounters 
The mosaic-like pattern of expression of TRAs, such that only a few cells in the medulla 
express a given self-antigen (BOX 1), poses obvious limitations on the likelihood that 
a given TRA is ‘seen’ at all by its cognate T cells. In addition, it is conceivable that the 
number of APCs that present a given antigen may directly affect the ensuing mode of 
CD4+ T cell tolerance. In this regard, it is of particular relevance that most models of 
thymocyte selection, particularly those based upon affinity and/or avidity, assume that 
cell fate decisions in the thymus are based on a single thymocyte–APC interaction. 
However, this may not, or at least not always, be the case.  
 
Real-time imaging of thymocyte motility in thymic slices showed that in the absence of 
cognate antigen, medullary thymocytes have relatively rapid motion in a ‘random walk’ 
pattern and scan their environment for cognate pMHC ligands through engaging in 5–
8 short-lived contacts with APCs per hour42,43. Administration of cognate peptide to 
such thymus slices resulted in the migratory arrest of specific CD8+ SP T cells within 
minutes, followed by their apoptotic cell death within a few hours 44. Thus, clonal 
deletion resulting from abundantly available antigen may indeed involve a single, yet 
sustained, thymocyte–APC interaction. By contrast, when cognate antigen was 
expressed endogenously in a TRA-like expression pattern in a model of steady-state 
negative selection of CD8+ T cells, there was no evidence for the migratory arrest of T 
cells. Instead, CD8+ SP cells continually migrated, albeit with decreased velocity, 
indicating that they had experienced one or several previous antigen encounter(s)42. 
Whereas these experimental systems focused on TCR-transgenic CD8+ SP T cells, a 
similar pattern of confined migration was observed for a fraction of polyclonal MHC 
class I-restricted and MHC class II-restricted medullary thymocytes42. Thus, it is 
possible that for CD4+ SP thymocytes also, particular modalities of self-antigen 
presentation do not deliver an immediate and persistent stop signal. In such a ‘multiple 
Klein et al. 
Nat Rev Immunol. Author manuscript. 8	
hit’ scenario, a mosaic-like pattern of antigen expression is more likely to result in 
transient TCR triggering, whereas ubiquitously expressed and presented self-antigens 
would provide continual TCR stimulation. 
 
Consistent with the idea that discontinuous TCR stimulation is favourable or even 
essential for Treg cell differentiation, FOXP3 induction upon in vitro stimulation of CD4+ 
SP T cells with CD3-specific antibodies was most efficient when the TCR stimulus was 
prematurely terminated or when, subsequent to an initial phase of TCR stimulation, 
phosphatidyl inositol 3-kinase (PI3K) or its downstream signalling modules — protein 
kinase B (also known as AKT1) or mechanistic target of rapamycin (mTOR) — were 
inhibited45. Along these lines, mathematical models have suggested a signal 
integration model of thymocyte selection that provides a conceptual framework to 
understand how the TCR stimulation history may determine the outcome of thymic 
selection based upon a synthesis of both sustained and transient TCR signalling 
levels46. This model posits that clonal deletion of thymocytes may result from a strong, 
isolated signalling event, whereas Treg cell differentiation may ensue from repeated, 
weak TCR stimulation, and it is clear how ubiquitous and high-level expression of self-
antigens versus mosaic-like and low-level expression of self-antigens may favour 
clonal deletion versus Treg cell differentiation (FIG. 3). 
 
In sum, a growing body of observations indicates that clonal deletion can result from a 
‘single hit’ of antigen that promotes immediate arrest of the thymocyte on the APC 
surface, which may in turn amplify the intensity and/or duration of TCR signalling43,47-
49. However, it remains to be seen whether, by contrast, Treg cell differentiation 
involves, or even requires, multiple antigen encounters.  
 
Thymic antigen-presenting cells 
Developing thymocytes may encounter self-antigens on various types of APC33, 
including classical dendritic cell (cDC) subsets50,51, plasmacytoid DCs (pDCs)52, B 
cells53,54, and cortical and medullary TECs55. It is widely accepted that all of these 
thymic APC subtypes can induce T cell tolerance. However, their relative contributions 
to shaping the polyclonal T cell repertoire remain poorly understood, with regards to 
both the spectrum of self-antigens that they display as well as whether self-antigen 
encounter on distinct APCs preferentially or even selectively results in clonal deletion 
or Treg cell induction. 
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Mouse models lacking cDCs or subsets of mTECs, or with absent or aberrant MHC 
class II expression on subclasses of thymic APCs, have been used to address these 
questions (reviewed in12). Irrespective of whether antigen presentation by DCs or 
mTECs was inhibited, these models showed an increase in the number of CD4+ SP T 
cells, which is thought to reflect the non-redundant contribution of the respective APCs 
to clonal deletion of MHC class II-restricted T cells55-57. By contrast, the overall size of 
the polyclonal Treg cell compartment was not markedly affected upon interfering with 
the capacity of individual APC subsets to contribute to central tolerance induction for 
CD4+ T cells. However, sequencing of TCRs on Treg cells in mice lacking DCs or with 
decreased MHC class II expression on mTECs clearly pointed to a non-redundant 
contribution of these APCs to shaping the Treg cell repertoire at the level of individual 
antigen specificities24. Thus, in both mouse models, distinct sets of TCRs were absent 
from the Treg cell repertoire and instead were present in the repertoire of conventional 
T cells. 
 
In sum, there is no evidence to suggest that a single thymic APC subset is specialized 
and required for either clonal deletion or Treg cell differentiation. Nonetheless, it is 
becoming increasingly clear that thymic APC subtypes, owing to differences in the way 
that they sample and process self-antigens, differ in their peptide–MHC ligandome 
(reviewed in33) (BOX 2). Irrespective of the ensuing mode of tolerance, the 
presentation of partly unique arrays of self-peptides by different APC subsets is 
expected to translate into a non-redundant role for these subsets in central tolerance 
to autoantigens that are not ubiquitously available.  
 
Costimulation and soluble factors 
In addition to having partly non-overlapping peptide–MHC ligandomes, thymic APC 
subsets may also differ in their capacity to provide non-antigenic signals that act on 
developing thymocytes simultaneously or in close temporal proximity to TCR 
stimulation. Such extrinsic cell fate determinants may be provided in the form of 
costimulatory molecules or soluble factors and they represent potential determinants 
of deletion versus diversion into the Treg cell lineage. 
 
 
 
 
Peptide‒MHC ligandome 
The repertoire of peptides that are bound by MHC molecules on a given cell type. 
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IL-2. Together with the TCR stimulus, IL-2 has a crucial role in promoting thymic Treg 
cell development58. The relationship between TCR and cytokine signals has been 
framed in terms of a two-step model, whereby strong TCR signals lead to the 
upregulation of expression of CD25 (also known as IL-2Rα), which confers high-affinity 
IL-2 binding and, in turn, promotes FOXP3 upregulation59,60. CD25+FOXP3– cells are 
present at a frequency of 2–3% in the steady-state CD4+ SP T cell compartment. A 
substantial fraction of these cells gives rise to mature CD25+FOXP3+ Treg cells upon in 
vivo transfer into an MHC class II-deficient thymus or upon in vitro culture with IL-2, 
which indicates that a fraction of CD25+FOXP3– CD4+ SP thymocytes are at an 
intermediate developmental stage, where TCR signals are dispensable and IL-2 is 
sufficient for the completion of Treg cell differentiation60. Further support for a model in 
which CD25 expression precedes the induction of FOXP3 in the majority of developing 
Treg cells comes from molecular timing studies in vivo61. However, there are also 
indications that some thymic Treg cells differentiate via a pathway in which the 
upregulation of FOXP3 expression precedes CD25 induction62,63. Moreover, other 
common cytokine receptor γ-chain family cytokines (γc cytokines), in particular IL-15, 
can have a redundant role in promoting Treg cell development62,64-66. 
 
Levels of IL-2 in the thymus are likely to be a limiting factor for Treg cell 
differentiation65,67, which raises questions about the cellular source(s) of IL-2. In a 
thymic tissue slice model that recapitulates many aspects of steady-state thymic Treg 
cell development, Il2–/– DCs were significantly less efficient in their ability to induce 
agonist-driven Treg cell development compared with Il2+/+ DCs, which suggests that 
APCs may simultaneously provide both IL-2 and the TCR ligand required for Treg cell 
differentiation68. 
 
 
 
 
 
Common cytokine receptor γ-chain family cytokines 
(γc cytokines). The heterodimeric or heterotrimeric receptors for at least six cytokines 
(IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21) share a common γ-chain (known as γc or 
CD132). The receptors for IL-2 and IL-15 also share the β-subunit (CD122), but contain 
distinct a-subunits (CD25 and CD215, respectively). Both a-subunits confer high-
affinity cytokine binding, but are not directly involved in signal transduction. 
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By contrast, a recent study using T cell-specific, B cell-specific or DC-specific 
conditional Il2 knockout showed that IL-2 derived from thymocytes themselves is 
necessary and sufficient for thymic Treg cell development, in particular in the absence 
of IL-1569. Importantly, this study also used mixed chimeras to show that in Il2–/– 
recipients of an equal mixture of wild-type and T cell-specific Il2-knockout bone 
marrow, IL-2-deficient and IL-2-sufficient thymocytes underwent Treg cell differentiation 
with identical efficacy, which indicates that autocrine IL-2 is dispensable for Treg cell 
differentiation and that IL-2 is instead provided by neighbouring T cells. 
 
The exact identity of the bystander T lineage cells that produce IL-2 to support Treg cell 
differentiation remains to be established, but CD4+ SP cells differentiating into the 
conventional CD4+ T cell lineage are obvious candidates. Intriguingly, SP thymocytes 
acquire the competence for IL-2 production upon TCR stimulation only gradually at a 
late phase of maturation70. It is therefore conceivable that the availability of IL-2 to drive 
the second step of Treg cell differentiation is restricted to the immediate vicinity of a few 
mature, pre-emigration, conventional SP T cells that produce IL-2 upon encountering 
rare agonist pMHC ligands (FIG. 4a). Consistent with this idea, in situ analyses showed 
that IL-2 protein is confined to ‘haloes’ surrounding a small number of IL-2-producing 
cells at the corticomedullary junction71. Interestingly, a fraction of both thymic cDCs 
and mTECs express the high-affinity CD25 chain of the IL-2 receptor, but not the 
signalling chain CD12269, which suggests that these APCs may capture T cell-derived 
IL-2 and restrict its free diffusion. Such local retention of IL-2 by neighbouring APCs 
may not only reinforce the spatial constraints in IL-2 availability, but also allow for trans-
presentation 72 of surface-bound IL-2 to developing Treg cells. 
 
 
 
 
Trans-presentation 
Cytokine trans-presentation is best established for IL-15, whereby signalling in a 
responder cell results from recognition of complexes of IL-15 with the high-affinity IL-
15Ra subunit on the surface of a ‘trans-presenting’ cell-type, which may itself produce 
IL-15. It is controversial whether the high-affinity IL-2Ra subunit (CD25) can bind IL-2 
independently of other receptor subunits and thereby elicit IL-2 signalling in trans.  
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The amount of IL-2 available to support thymic Treg cell generation is not only limited 
by the number of IL-2-producing cells, but also controlled by a negative-feedback loop 
in which mature Treg cells restrain the de novo differentiation of Treg cells (FIG. 4b). 
Using thymic tissue slices, it was shown that existing thymic Treg cells within the thymic 
slice environment limited cytokine availability and inhibited the development of new 
Treg cells68. In a further intriguing twist, Treg cells can migrate back to the thymus from 
the periphery and so may place additional pressure on the system by also competing 
for IL-273. Curiously, the recirculation of peripheral Treg cells requires AIRE, which 
seems to reflect a role of AIRE in chemokine production by mTECs rather than in 
promoting TRA expression74. It remains to be established whether recirculation of Treg 
cells to the thymus is developmentally controlled, involves environmental triggers 
and/or selectively applies only to certain antigen specificities. 
 
Competition for IL-2 per se is an antigen-independent process, but it also has 
implications for another enigmatic aspect of thymic Treg cell differentiation — namely, 
the intraclonal competition between Treg cell precursors of shared TCR specificity. 
Models in which the fate of a thymocyte is solely specified by its TCR predict that 
transgenic expression of a Treg cell-derived TCR would lead to enhanced Treg cell 
development. However, initial analyses of transgenic mice with TCRs cloned from 
naturally occurring Treg cells of unknown specificity showed that such monoclonal 
systems have only very small numbers of FOXP3+ cells13,14. Efficient Treg cell 
development was restored upon reducing the frequency of cells bearing the respective 
Treg cell-derived TCR13,14, which indicates that Treg cell differentiation involves a limiting 
niche that is saturated at very low clonal frequencies. Competition for antigen is likely 
to be a rate-limiting determinant that restrains Treg cell differentiation at step one. This 
is supported by the observation that a gradual reduction of the frequencies of T cell 
precursors resulted in a proportional increase in the level of TCR stimulation in 
developing Treg cells75. The mosaic-like expression pattern of many self-antigens in the 
thymus suggests that the thymus contains plenty of different niches tailored to promote 
the development of Treg cells with distinct self-antigen specificities. Considering the 
evidence for linked display of agonist pMHC complexes and trans-presented IL-2 by 
the same APC, it is conceivable that within these niches, Treg cell precursors may 
compete for access to IL-2 as well as antigen. It is tempting to speculate that mature 
Treg cells may preferentially deplete sources of IL-2 associated with the same APC that 
selected them originally. This would primarily limit the development of Treg cells with 
related specificities, which potentially explains why low-frequency Treg cell precursors 
develop more efficiently than high-frequency Treg cell precursors (FIG. 4c).  
Klein et al. 
Nat Rev Immunol. Author manuscript. 13	
 
How do these findings relate to clonal deletion? Whereas competition for a 
developmental niche that is defined by the availability of IL-2 may influence whether or 
not an antigen-primed CD25+FOXP3– thymocyte precursor gives rise to a mature 
CD25+FOXP3+ Treg cell, the fate of those CD25+FOXP3– thymocytes that lose the 
competition for IL-2 remains to be established; it may depend on the developmental 
stage at which they encounter antigen, the type of APC and the affinity of the TCR. On 
the one hand, it is possible that IL-2-deprived autoreactive thymocytes may revert to a 
conventional CD4+ T cell fate and leave the thymus as ‘escapees’ from central 
tolerance induction. On the other hand, given the dual function of IL-2 as a factor for 
both differentiation and survival, it seems more likely that these cells die. Consistent 
with that idea, TCR-transgenic presumptive Treg cells that were incapable of signalling 
via CD25 were lost from the T cell repertoire76, which suggests that for cells that are 
poised to enter the Treg cell lineage, IL-2 is indeed a crucial determinant of life or death. 
Surprisingly little is known with regards to the possibility that classical clonal deletion 
may likewise involve intermediates responsive to γc cytokines, but it is noteworthy that 
IL-7 can negate negative selection in particular models of clonal deletion77,78. 
 
CD28. Cd28–/– or Cd80–/–Cd86–/– mice fail to generate a Treg cell pool of normal size79. 
The small number of mature FOXP3+ Treg cells in the thymus of Cd28–/– mice is 
reminiscent of the phenotype of Il2–/– mice. However, although costimulation has been 
implicated in cytokine production, the Treg cell deficiency in Cd28–/– or Cd80–/–Cd86–/– 
mice is not caused by deprivation of exogenous cytokines, but primarily reflects a T 
cell-intrinsic function of the CD28–B7 signalling axis. For example, the failure of Cd28–
/– thymocytes to efficiently enter the Treg cell lineage is not rescued by the presence of 
bystander Cd28+/+ cells80. 
 
 
 
 
 
CD28–B7 signalling axis 
CD28 is the prototypical costimulatory receptor expressed on the surface of T cells. It 
can bind to CD80 (also known as B7.1) or CD86 (also known as B7.2) on the surface 
of antigen presenting cells. 
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Costimulation through CD28 is believed to function simultaneously to the TCR signal 
at an early stage of Treg cell differentiation40,81,82, and one possibility is that its role is to 
increase the aggregate magnitude of the underlying agonist stimulus. In the context of 
models of Treg cell differentiation versus clonal deletion centred on signal strength, one 
may therefore hypothesize that for cells that engage in TCR-pMHC interactions of 
relatively low affinity or avidity, costimulation may favour Treg cell generation over the 
differentiation of conventional T cells. By contrast, for TCR-pMHC interactions of 
relatively high affinity and/or avidity, costimulation may tip the balance between Treg 
cell differentiation and clonal deletion in favour of the latter. According to such a 
scenario, the smaller Treg cell compartment of CD28-deficient mice would be expected 
to contain a substantially altered TCR repertoire, on the one hand depleted of cells 
that have escaped into the conventional T cell repertoire, and on the other hand 
harbouring TCR clones that otherwise would have undergone deletion. However, the 
TCR composition of the residual Treg cell pool of Cd28–/– mice is surprisingly similar to 
that of wild-type mice, which suggests that CD28 does not function primarily to amplify 
the TCR signal strength, but to provide a qualitatively distinct signal that somehow 
supports the formation of a Treg cell compartment of normal size81. The possibility that 
CD28 drives the proliferative expansion of a small precursor pool of Treg cells has been 
excluded83, so it seems that CD28 functions in thymic Treg cell generation through a 
true lineage-specifying function and/or through a pro-survival function. In keeping with 
the latter function, and in further evidence against a role for costimulation in signal 
amplification, CD28 deficiency in a TCR-transgenic model of agonist-driven Treg cell 
differentiation resulted in the physical loss of presumptive Treg cells rather than their 
escape as conventional FOXP3– T cells83. These findings are consistent with CD28 
signalling preventing the death of TCR-activated Treg cell precursors. They suggest 
that whether or not CD28-mediated costimulation accompanies the underlying 
agonistic TCR signal can be a binary switch that specifies diversion into the Treg cell 
lineage or clonal deletion, respectively. Intriguingly, observations in other cellular 
contexts indicate that CD28 can negatively regulate the expression of the pro-apoptotic 
protein BCL-2-interacting mediator of cell death (BIM; also known as BCL2L11)84, 
which is an essential mediator of classical clonal deletion85. However, BIM deficiency 
does not rescue the thymic Treg cell defect in Cd28–/– mice86, which indicates that CD28 
signalling in Treg cell precursors either suppresses other death pathways or, in addition 
to suppressing BIM, concomitantly has a lineage-specifying function.  
 
The role of CD28-mediated costimulation in classical clonal deletion has been 
controversial. In vitro experiments showed that CD28 signalling can increase the death 
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of TCR-stimulated thymocytes77,87. By contrast, numerous in vivo studies, involving 
either superantigen-reactive T cells or TCR-transgenic systems of negative selection, 
have failed to support a crucial requirement for CD28 in this process88-92. A more recent 
investigation revisited the interpretation that costimulation via CD28 is dispensable for 
deletional tolerance in vivo and provided an unexpected new twist. In this study, 
superantigen-reactive T cells were absent from the mature thymocyte compartment 
irrespective of whether or not costimulation was available, but in the absence of CD28 
this was not a consequence of their clonal deletion, but resulted from their re-direction 
into a CD4−CD8−TCRαβ+ compartment that may be the precursors of CD8αα+ 
intraepithelial lymphocytes 93. Thus, in the case of superantigen-mediated clonal 
deletion of thymocytes, CD28 seems to relay a signal that favours cell death over 
another agonist-driven cell fate. 
 
Taking the results together, it seems that CD28-mediated costimulation is crucially 
required for both clonal deletion, at least as far as superantigen-mediated T cell death 
is concerned, and the efficient formation of a Treg cell compartment of normal size. 
Somewhat paradoxically, during Treg cell differentiation, CD28 seems to counteract cell 
death, whereas in the context of clonal deletion, it seems to promote cell death. This 
is reminiscent of earlier observations in T cell hybridomas that showed, depending on 
the signalling context, that CD28-mediated costimulation can induce either pro-
apoptotic or anti-apoptotic genes94, and it will be interesting to dissect whether distinct 
molecular effectors downstream of CD28 operate in Treg cell differentiation versus 
clonal deletion. 
 
 
 
 
 
 
CD8aa+ intraepithelial lymphocytes 
Intraepithelial lymphocytes are enriched in ab T cells that express CD8aa 
homodimers. These cells are thought to have a crucial function in immune regulation 
at mucosal interfaces, in particular in the intestine. There is evidence that CD8aa+ 
intraepithelial lymphocytes emerge from agonist selection in the thymus, but their exact 
developmental origin remains poorly understood.  
 
Klein et al. 
Nat Rev Immunol. Author manuscript. 16	
Transforming growth factor-β. Mice lacking transforming growth factor-β1 (TGFβ1) 
or with T cell-specific deletion of TGFβ receptors develop a fatal inflammatory disorder, 
which highlights the crucial role of TGFβ in T cell tolerance95. Owing to the pleiotropic 
functions of TGFβ in the immune system, it has been challenging to conclusively 
dissect the role of TGFβ during thymocyte differentiation and central tolerance 
induction. Thus, although it is widely accepted that TGFβ supports the in vitro 
conversion of naive T cells into induced FOXP3+ Treg cells96 and is crucial for the in 
vivo conversion of naive T cells into peripherally derived Treg cells in physiological as 
well as therapeutic settings97,98, an analogous role for TGFβ in thymic Treg cell 
differentiation has remained contentious. Initial analyses of TGFβ-deficient mice 
showed that these animals have more, rather than fewer, thymic Treg cells when 
analysed at around two weeks of age99,100. However, it was later found that mice 
lacking the TGFβ receptor on T cells are essentially devoid of thymic Treg cells when 
analysed at an earlier time point, and that the apparently normal numbers of thymic 
Treg cells at a later stage were secondary to systemic inflammation and increased 
levels of IL-2, which, in turn, expand what would otherwise be a very small Treg cell 
population101. These data clearly show that TGFβ is required for the formation of a 
thymic Treg cell pool of normal size; however, different underlying mechanisms have 
been proposed. 
 
On the one hand, it has been suggested that the function of TGFβ in the thymus is as 
a survival factor. Apoptosis was massively increased among FOXP3+ thymocytes 
lacking the TGFβ receptor86. Of note, cell death in the context of classical clonal 
deletion mediated by CD3-specific antibody or endogenously expressed neo-antigen 
was also increased in the absence of TGFβ signalling, which indicates that the anti-
apoptotic function of TGFβ is not restricted to cells that have entered the Treg cell 
lineage, but applies more generally to all thymocytes that receive an agonist TCR 
stimulus86,102. Ablation of the pro-apoptotic molecule BIM restored the thymic Treg cell 
pool to normal size in the absence of TGFβ signalling, which suggests that TGFβ is 
required to inhibit BIM-dependent apoptosis during thymic Treg cell differentiation, but 
is not essential for the induction of FOXP3 expression. In line with this, a conserved 
cis-element in the Foxp3 gene containing a TGFβ response element is crucial for the 
induction of peripherally derived Treg cells in gut-associated lymphoid tissues but is 
dispensable for thymic Treg cell differentiation98,103. 
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On the other hand, some findings support the idea that TGFβ not only keeps Treg cells 
alive but also specifies entry into the Treg cell lineage. For example, the thymic Treg cell 
compartment is not decreased in size when the TGFβ receptor is inactivated late in 
thymic Treg cell differentiation using a Foxp3-Cre system104. This indicates that TGFβ 
signalling is dispensable for the survival of mature thymic Treg cells, although it remains 
possible that it exerts a crucial pro-survival function at an earlier stage of thymic Treg 
cell differentiation. Upon intrathymic injection of polyclonal CD4–CD8– thymocytes, 2–
3% of these cells give rise to FOXP3+CD4+ SP cells, and this is believed to mimic 
steady-state Treg cell differentiation. TGFβ receptor-deficient thymocyte precursors 
failed to give rise to FOXP3+ Treg cells in this setting, which indicates that TGFβ 
signalling has a direct cell-intrinsic role in the initiation of Foxp3 transcription104. As a 
note of caution, however, it is not known whether the small fraction of input cells that 
would normally assume a Treg cell fate indeed failed to initiate Foxp3 transcription or 
instead failed to survive in this study. 
 
In conclusion, further study is required to unravel the exact role(s) of TGFβ during 
thymic selection, although it is reasonable to assume that a general pro-survival 
function of TGFβ for TCR-signalled thymocytes and a function as a bona fide 
differentiation factor for Treg cells are not mutually exclusive. Irrespective of its exact 
function, the net effect of TGFβ in the thymus seems to be to restrain clonal deletion 
while supporting Treg cell development. Consequently, TGFβ is expected to adjust the 
balance between these two modes of central tolerance, which raises questions 
regarding the source(s) of TGFβ in the thymic microenvironment and whether the 
availability of TGFβ is subject to temporal and spatial regulation. The total amount of 
active TGFβ in the thymus gradually increases over the neonatal period104, showing a 
strong correlation with the delayed emergence of the first Treg cells at around day 3 
after birth38. Intriguingly, the extent of thymocyte apoptosis seems to directly control 
the supply of intrathymic TGFβ, whereby contact with dying thymocytes promotes 
TGFβ production by thymic macrophages and DCs (and possibly also TECs)104; this 
suggests some form of cross-regulation between clonal deletion and Treg cell 
differentiation105. 
 
Perspectives 
Recent data have revealed intriguing correlations between ubiquitous antigen 
expression in the thymus and clonal deletion of thymocytes, and between TRA-like 
mosaic antigen expression in the thymus and diversion of thymocytes into the Treg cell 
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lineage. We have discussed how these findings may relate to thymocyte-intrinsic and 
thymocyte-extrinsic determinants that specify the fate of autoreactive MHC class II-
restricted thymocytes. As a consequence, the thymus-derived Treg cell repertoire 
should have a strong bias towards the recognition of peripheral antigens, while being 
largely devoid of TCR specificities for widely expressed antigens. This remains to be 
tested. 
 
None of the cell fate determinants outlined here has emerged as a single switch 
between clonal deletion and clonal diversion, and a coherent model that incorporates 
all potential parameters is lacking. The strength of the underlying TCR stimulus is likely 
to be a prime determinant, but it remains unclear how incremental variations in TCR 
signalling intensity are translated into a binary cell fate decision. For example, almost 
nothing is known regarding how TCR signalling events in the context of step one of the 
two-step model of Treg cell differentiation may qualitatively or quantitatively differ from 
a TCR stimulus that results in clonal deletion. Similarly, the molecular basis of 
differential integration of TCR signals and non-antigenic signals (costimulation and 
cytokines) at subsequent stages of thymocyte development is only poorly understood, 
and it will be interesting to unravel how stage-specific sensitization or de-sensitization 
of the TCR signalling machinery and/or transcriptional or epigenetic control may poise 
thymocytes for particular fate decisions. 
 
With regards to a multiple hit model of thymocyte selection, improved intravital 
methodologies to visualize antigen recognition events simultaneously with the ensuing 
cell fate choice will be necessary to dissect whether sequential and intermittent 
encounters with agonist ligands in vivo are a prerequisite for Treg cell differentiation or 
simply reflect the pre-emigration behaviour of Treg cells subsequent to and independent 
of the actual lineage-instructing TCR stimulus. Of note, it remains to be seen how a 
model of Treg cell generation that is based upon serial, short-lived encounters with 
antigen can be reconciled with a limiting niche model that presumes prolonged 
retention of Treg cells and competition for antigen and IL-2 in the instructing 
microenvironment. 
 
Finally, a deeper understanding of the determinants of clonal deletion versus Treg cell 
diversion in the thymus is complicated by the fact that both cell fates might be achieved 
via pathways that are more heterogeneous than commonly assumed. On the one 
hand, there are hints that classical clonal deletion differs in its requirements for 
costimulation and/or apoptotic effector pathways depending on the developmental 
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stage of thymocytes41. On the other hand, Treg cell development may occur via different 
pathways that are characterized by differences in the order of expression of CD25 and 
FOXP3. Importantly, irrespective of whether Treg cell differentiation proceeds via 
CD25+FOXP3– or CD25–FOXP3+ intermediates, both pathways of Treg cell 
differentiation seem to involve apoptosis-prone transitional stages at which cells 
compete for cytokines as survival factors. Thus, a substantial fraction of TCR-signalled 
Treg cell intermediates may die because of cytokine deprivation, which raises the 
possibility that blunted Treg cell differentiation represents a significant, if not major, 
pathway of clonal deletion at the CD4+ SP stage. 
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Box 1 | Promiscuous gene expression in the thymus 
Tightly controlled expression of genetic programmes is a hallmark of tissue identity. 
However, in violation of this rule, medullary thymic epithelial cells (mTECs) express a 
large number of mRNAs encoding self-antigens whose expression is otherwise under 
stringent developmental, spatial and temporal control, known as tissue-restricted 
antigens (TRAs)106,107. The expression of more than three thousand TRA transcripts is 
controlled by the autoimmune regulator protein (AIRE). AIRE lacks features of classical 
transcription factors and instead seems to facilitate ectopic transcription indirectly 
through binding to inactive histone marks and promoting the subsequent recruitment 
of factors associated with chromatin opening, release of stalled RNA polymerase and 
transcript maturation108,109. AIRE is essential for T cell tolerance, as is evident from the 
autoimmune manifestations that occur in AIRE-deficient humans and mice. 
 
Promiscuous gene expression of TRAs is not fully abolished in the absence of AIRE110, 
and recent data suggest that the transcription factor Fez family zinc finger protein 2 
(FEZF2) might be a second, independent regulator of promiscuous gene 
expression111. In support of this, FEZF2-dependent TRA expression is not affected in 
AIRE-deficient mTECs, and FEZF2 deficiency in thymic epithelium elicits a spectrum 
of autoimmune manifestations that is partly distinct from those in AIRE-deficient mice. 
 
At the population level, mTECs express the highest number of genes (>85% of all 
protein coding transcripts) observed in any cell type112 and thereby provide a 
comprehensive representation of peripheral self-antigens. However, the expression of 
a given TRA is, in many cases, confined to only 1–3% of all mTECs33,107. For example, 
pioneering early studies showed that an adult mouse thymus contains a few hundred	
cells that express pancreas-specific TRAs113, whereas the total number of mTECs is 
in the order of 100,000. Recent comparisons of gene expression profiles of mTECs at 
the single cell level confirmed that there is a substantial degree of cell-to-cell variation 
in the transcriptomes of mTECs, which further substantiates the idea that promiscuous 
gene expression entails a stochastic component33,112,114,115. 
 
 
 
 
Ectopic transcription 
Expression of a tissue-specific mRNA in a cell type where the respective gene product 
does not have any obvious function.  
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Box 2 | The peptide–MHC class II ligandomes of thymic antigen-presenting cells 
Thymic antigen-presenting cell (APC) subsets are expected to display partly non-
overlapping peptide–MHC class II ligandomes, owing to differences in their origin and 
the way in which they capture and process antigens (reviewed in33). Cortical thymic 
epithelial cells (cTECs) express unusual proteases whose proteolytic activity differs 
from the antigen processing that occurs in other APCs. These cTEC-specific proteases 
are not at all or only weakly expressed in other cell types and they have been 
implicated in the generation of unique MHC class I-bound and MHC class II-bound 
peptides for positive selection. Medullary TECs (mTECs), like cTECs, are inefficient in 
loading extracellular self-antigens onto MHC class II molecules. Instead, both cTECs 
and mTECs seem to preferentially use non-canonical MHC class II loading pathways 
for endogenous antigens116. In the case of mTECs, a peptide–MHC class II ligandome 
predominantly composed of endogenously derived substrates is expected to include 
tissue-restricted antigens (TRAs). Variability in the expression of TRAs between 
individual mTECs is likely to result in a corresponding degree of variability also in their 
peptide–MHC class II ligandomes. 
 
Classical dendritic cells (cDCs) in the thymus segregate into at least two subsets50. 
Migratory CD8−SIRPα+ cDCs migrate into the thymus from the circulation and their 
peptide–MHC class II ligandomes may contain epitopes derived from self-antigens that 
have been captured in the periphery117. Resident CD8+SIRPα− cDCs arise through 
intrathymic differentiation. Similar to their migratory counterparts, they efficiently 
sample extracellular sources of self-antigen. Although both types of thymic cDC may 
thereby capture and present mTEC-derived antigens, resident cDCs may be 
particularly efficient in doing so118, as supported by T cell receptor repertoire studies24. 
Approximately one third of thymic DCs are plasmacytoid DCs (pDCs); pDCs are of 
extrathymic origin and are capable of inducing central tolerance to self-antigens that 
have been captured at peripheral sites52.  
 
Thymic B cells may originate from intrathymic B lymphopoiesis, but they can also be 
of extrathymic origin. Unlike mainstream peripheral B cells, thymic B cells have 
prominent APC features, such as high levels of expression of MHC class II molecules 
and CD80. Curiously, they also express AIRE, but the functional significance of this 
finding remains to be established53,54. It has been speculated that the self-peptide–
MHC class II ligandome of thymic B cells may mirror that of germinal centre B cells 
and/or contain self-antigens that have been captured via autoractive B cell receptors. 
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Figure Legends 
Figure 1 │ Signal strength models of clonal deletion versus Treg cell 
differentiation. The term affinity describes the strength of a single interaction between 
a T cell receptor (TCR) and its peptide–MHC (pMHC) ligand, whereas the term avidity 
is proportional to the multiplicity of such interactions. (a) According to an affinity-based 
model of thymocyte development, at a given fixed density of cognate pMHC in the 
thymus, T cells bearing the highest affinity TCRs are removed from the repertoire by 
clonal deletion, whereas T cells bearing TCRs of intermediate affinity are diverted into 
the regulatory T (Treg) cell repertoire. T cells bearing TCRs of low affinity ‘escape’ into 
the periphery as conventional T cells. Although this prediction has so far not been 
addressed in a polyclonal setting, the affinity-based model is supported by a study 
showing that at a fixed level of neo-self-antigen expression, the efficiency of Treg cell 
selection was directly correlated with the reactivity of different TCRs119. (b) An avidity-
based model posits that in addition to the TCR affinity, the density of the pMHC ligand 
is also crucial. At a given fixed TCR affinity, increasing or decreasing the density of 
antigen presented on thymic antigen-presenting cells will bias the cell fate towards 
either clonal deletion or Treg cell differentiation, respectively. Several experimental 
observations are consistent with this model. First, TCR-transgenic models have shown 
a clear correlation between antigen expression levels and the ensuing cell fate20,120. 
Second, the titrated administration of agonist peptide to TCR-transgenic fetal thymic 
organ cultures or through intravenous injection into adult mice revealed a positive 
correlation between agonist concentration and the number of Treg cells; above a certain 
threshold, further increasing the peptide dose resulted in thymocyte deletion121,122. 
Third, at fixed levels of antigen expression, attenuating cognate antigen presentation 
through the knockdown of MHC class II expression resulted in decreased clonal 
deletion and increased emergence of Treg cells55. Finally, low-affinity or high-affinity 
peptide ligands for the same TCR can instruct Treg cell differentiation with equal 
efficiency provided that the density of the low-affinity ligand is correspondingly 
higher123. 
 
Figure 2 │ How T cell-intrinsic developmental ‘windows of opportunity’ may 
influence the mode of CD4+ T cell tolerance. Immature thymocytes have an inherent 
predisposition to undergo apoptotic cell death upon agonist antigen encounter, 
whereas fully mature T cells respond to antigenic stimulation by proliferation and the 
acquisition of effector function. The transition from a deletion-sensitive to a deletion-
resistant state seems to coincide with progressive thymocyte maturation at the single 
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positive (SP) stage. Thus, cortical double positive (DP) thymocytes and medullary SP 
thymocytes with an immature (HSAhi) phenotype are susceptible to clonal deletion, 
whereas more mature (HSAlow) cells are not41. It remains poorly understood when and 
where during thymocyte development the capacity to undergo regulatory T (Treg) cell 
differentiation is established, but it is conceivable that concomitant with gradually 
losing their susceptibility to deletion, medullary CD4+ SP thymocytes enter a transient 
phase of inclination towards the Treg cell lineage. Consistent with this, efficient Treg cell 
differentiation was observed when the developmental window for clonal deletion was 
experimentally bypassed by intrathymic injection of semi-mature, antigen-naive T cell 
receptor (TCR)-transgenic CD4+ SP cells into a microenvironment in which clonal 
deletion was the prevalent tolerance mechanism in the steady state40. 
 
Figure 3 │  Model for thymocyte integration of TCR signalling strength and 
number of antigen encounters. (a) Antigens that are expressed ubiquitously and 
presented at high levels — high levels of peptide–MHC (pMHC) shown in dark red — 
on thymic antigen-presenting cells (APCs) may favour clonal deletion of specific 
thymocytes through the induction of an isolated strong T cell receptor (TCR) signal. 
Immediate arrest of strongly TCR-signalled thymocytes on the APC surface may 
prolong the duration of TCR signalling and thereby establish a feed-forward loop that 
amplifies the aggregate signal input. (b) A mosaic pattern of self-antigen expression 
and presentation at comparably low levels (as indicated by the lighter red shading of 
thymic APCs) — as is typical for tissue-restricted antigens — may allow for serial, yet 
temporally separated, sub-threshold antigen encounters during continual migration of 
thymocytes through the thymic medulla. This mode of antigen recognition was 
suggested to favour regulatory T (Treg) cell differentiation46.  
 
Figure 4 │Model of limited developmental niches for antigen-specific Treg cells. 
(a) A thymic niche for regulatory T (Treg) cell development is defined by a rare antigen-
presenting cell (APC) that presents a particular, possibly tissue-restricted antigen 
(TRA)-derived, agonist self-peptide and by an IL-2 source in the immediate vicinity. IL-
2 produced by a relatively mature, conventional self-reactive CD4+ single positive (SP) 
thymocyte (possibly an escapee from clonal deletion) remains associated with the 
niche as a result of limited diffusion of IL-2 and/or the capture and trans-presentation 
of IL-2 by the IL-2 receptor α-subunit (IL-2Rα) expressed on the APC. The Treg cell 
progenitor receives both a strong T cell receptor (TCR) signal and IL-2, allowing its 
development into a mature forkhead box protein P3 (FOXP3)+ Treg cell. (b) TCR-
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specificity-independent feedback inhibition of Treg cell differentiation. Mature Treg cells 
in the thymus, including both recently differentiated cells and re-immigrants from the 
peripheral circulation, require and consume IL-2 as a survival factor and thereby 
deplete IL-2 from the thymic niche. IL-2 depletion limits the ability of newly TCR-primed 
(step one) thymocyte progenitors to undergo step two of Treg cell differentiation. IL-2-
deprived progenitors may either revert to the conventional T cell lineage or, perhaps 
more likely, undergo deletion. (c) Intraclonal competition for antigen and IL-2 between 
Treg cell progenitors of identical specificity. The first thymocyte progenitor (orange) that 
enters the thymic niche undergoes complete maturation into a Treg cell (left panel). 
Once a mature Treg cell, this cell may ‘sequester’ cognate pMHC complexes and 
deplete local IL-2, thereby interfering with step one (middle panel) and/or step two 
(right panel), respectively, of Treg cell differentiation of subsequently incoming 
progenitors (blue and green) of the same specificity. The alternative fate of 
outcompeted precursors could be escape from central tolerance induction to become 
conventional T cells (more likely in the case of competition for antigen) or deletion 
through apoptosis (more likely in the case of competition for IL-2). Both types of 
intraclonal competition would require, or at least be enhanced by, prolonged retention 
of recently matured Treg cells in the selecting niche. 
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